Renal function in children with heart transplantation after switching to CNI‐free immunosuppression with everolimus

作者: Kachina Behnke-Hall , Juergen Bauer , Josef Thul , Hakan Akintuerk , Katharina Reitz

DOI: 10.1111/J.1399-3046.2011.01550.X

关键词:

摘要: Renal impairment because of CNI contributes to long-term morbidity. Therefore, avoiding or sparing treatment strategies are important. In this article, we describe the results a CNI-free protocol with regard recovery renal function. Twenty-eight patients heart transplantation were switched from regimen everolimus and mycophenolate, when cGFR was <75 mL/min/1.73 m(2). all patients, stopped, trough levels 5-8 ng/L achieved. Serum creatinine determined before after 6 12 months. Median serum decreased 1.2 mg/dL (range 0.7-3.7) 1.0 0.6-1.8) 0.5-1.9) 47.81 18.3-72.6) m(2) 63.1 37.8-108.7) at six months 64.8 37.7-106.6) All changes baseline statistically significant (p < 0.05). Adverse events infections (n = 3) rejections 3). Therapy discontinued in four patients. Conversion immunosuppression resulted improvements function within withdrawal. Side effects common. However, more studies required demonstrate effectiveness children.

参考文章(58)
G. B. Haycock, G. J. Schwartz, Adrian Spitzer, C. M. Edelmann, A Simple Estimate of Glomerular Filtration Rate in Children Derived From Body Length and Plasma Creatinine Pediatrics. ,vol. 58, pp. 259- 263 ,(1976)
C.D. Garcia, V.B. Bittencourt, A.B. Alves, V.D. Garcia, A. Tumelero, J.S. Antonello, D. Malheiros, Conversion to Sirolimus in Pediatric Renal Transplantation Recipients Transplantation Proceedings. ,vol. 38, pp. 1901- 1903 ,(2006) , 10.1016/J.TRANSPROCEED.2006.06.063
Markus Rothenburger, Andreas Zuckermann, Christoph Bara, Manfred Hummel, Martin Strüber, Stephan Hirt, Hans Lehmkuhl, Recommendations for the use of everolimus (Certican) in heart transplantation: results from the second German-Austrian Certican Consensus Conference. Journal of Heart and Lung Transplantation. ,vol. 26, pp. 305- 311 ,(2007) , 10.1016/J.HEALUN.2007.01.010
Clifford Chin, David C Naftel, Tajinder P Singh, Elizabeth D Blume, Helen Luikart, Daniel Bernstein, Pat Gamberg, James K Kirklin, W Robert Morrow, Pediatric Heart Transplant Study Group, Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience. Journal of Heart and Lung Transplantation. ,vol. 23, pp. 178- 185 ,(2004) , 10.1016/S1053-2498(03)00059-7
S. Schubert, H.B. Lehmkuhl, M. Huebler, R. Hetzer, F. Berger, 318: Comparison of De Novo Everolimus, AZA and MMF in Cyclosporine Based Immunosuppressive Protocol in Pediatric Heart Transplant Patients Journal of Heart and Lung Transplantation. ,vol. 29, ,(2010) , 10.1016/J.HEALUN.2009.11.331
Kenneth A Bodziak, Donald E Hricik, Conversion from calcineurin inhibitors to mTOR inhibitors Current Opinion in Organ Transplantation. ,vol. 12, pp. 351- 356 ,(2007) , 10.1097/MOT.0B013E32819F8EF4
Leonard C. Hymes, Barry L. Warshaw, Sirolimus in pediatric patients: results in the first 6 months post-renal transplant. Pediatric Transplantation. ,vol. 9, pp. 520- 522 ,(2005) , 10.1111/J.1399-3046.2005.00324.X
Robert Ettenger, Peter‐Friedrich Hoyer, Paul Grimm, Nicholas Webb, Chantal Loirat, John D Mahan, Mark Mentser, Patrick Niaudet, Gisela Offner, R Vandamme‐Lombaerts, J Mark Hexham, Everolimus Pediatric Study Group, None, Multicenter trial of everolimus in pediatric renal transplant recipients: results at three year. Pediatric Transplantation. ,vol. 12, pp. 456- 463 ,(2008) , 10.1111/J.1399-3046.2007.00832.X
Andreas Zuckermann, Nicolas Manito, Eric Epailly, Arnt Fiane, Christoph Bara, Juan F. Delgado, Hans Lehmkuhl, Heather Ross, Howard Eisen, Jeremy Chapman, Hannah Valantine, Multidisciplinary Insights on Clinical Guidance for the Use of Proliferation Signal Inhibitors in Heart Transplantation The Journal of Heart and Lung Transplantation. ,vol. 27, pp. 141- 149 ,(2008) , 10.1016/J.HEALUN.2007.08.014